American Resources CEO discusses ReElement Technologies' partnership with Principal Minerals - ICYMI
2 Blue-Chip Behemoths For Retirement Income
Smaller Industrials Names Seeing Surging Growth: Here's Why
Walmart's latest AI innovations represent a shift for big retail
Marvell: Load Up Now While The Market Runs For Cover
Down 50%, Should You Buy the Dip on C3.ai?
Elliott sees opportunities to create value at warehouse REIT Rexford Industrial
4 Dividend Stocks to Double Up on Right Now -- Including United Parcel Service and Pfizer
Top 2 sports betting stocks to buy ahead of NFL season
CAPR DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Capricor Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – CAPR
Nvidia has $57 billion in cash. Wall Street has ideas about what to do with it.
New REDUCE-IT® Analyses Presented at ESC 2025 Include Data Showing VASCEPA®/VAZKEPA® (Icosapent Ethyl) Therapy Resulted in 9% Fewer Total Hospitalizations & Reduces Cardiovascular Disease Risk in Certain High-Risk Patient Subgroups
Should You Buy Nu Holdings While It's Below $15?
Top 5 Dividend Stocks Yielding Over 5% for Effortless Passive Income
U.S. Gold secures power deal for CK Gold Project - ICYMI
Green Plains: Transforming Ethanol Production From Zero To Hero
The 5 Best Dividend Stocks to Buy Now
Rolls-Royce weighs funding options, including IPO, for small nuclear unit, FT reports
PTY: Attractive Valuation And Growth Potential From Interest Rate Cuts
REET Vs. VNQ: Investing In REITs Should Come With Global Diversification
Zscaler: Paying Up For The Future Of Cybersecurity
General Motors (NYSE: GM) Price Prediction and Forecast 2025-2030 (September 2025)
Always Buy Simon Property Group's Preferred Stock When It Is Reasonably Priced
Need $2000 in Passive Income? Invest Just $5000 in 3 Strong-Buy Rated Stocks
Is Oklo Stock a Buy Now?
ANRO DEADLINE: ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Alto Neuroscience, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ANRO
If You'd Invested $1,000 in CRLBF 5 Years Ago, Here's How Much You'd Have Today
Capturing AI's Upside: ARTY's Concentrated Play On Tomorrow's Winners
Tilray Brands: Momentum Now, Fundamentals Later
2 Top AI Stocks Prominent Billionaires Are Buying
Acoramidis Demonstrates Statistically Significant Reduction in Cardiovascular Mortality (CVM) through Month 42 of the ATTRibute-CM Open Label Extension
Micron: Time To Jump Back On The AI Bullet Train (Rating Upgrade)
Huge News for Qualcomm Investors
SLYG: Skewed Towards Tariff Trouble
Should You Buy the Schwab US Dividend Equity ETF Instead of Picking Individual Stocks?
Time to Buy the Dip on Archer Aviation Stock Below $10?
Should You Buy SoFi While It's Below $30?
ROSEN, A LEADING LAW FIRM, Encourages Altimmune, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ALT
1 Reason I Think Walmart Stock Is a Warren Buffett-Worthy Investment in 2025
Celestica's Growth Story: Why It Still Makes Sense To Buy Despite High Valuation
Better High-Yielding Dividend Stock: Realty Income vs. Pfizer
Morgan Stanley Direct Lending: Consistent Performer With A Rockbottom Valuation
EQT: Benefiting From Natural Gas Fundamentals
Prediction: IonQ Stock Will Soar Over the Next 5 Years. Here's 1 Reason Why
Meta Platforms Pauses AI Spend. Here's Why That's a Good Thing For Investors
Intel accelerates CHIPS act funding, receives $5.7B ahead of schedule
1 Reason Berkshire Hathaway (BRK.B) Is One of the Best Financial Stocks You Can Buy Today
Carnival Stock Is Crushing the Market -- Time To Buy?
3 Things Investors Should Know as the Crypto Treasury Trend Continues
Warren Buffett Just Sold $4 Billion of Apple Stock. He Used $1.5 Billion of the Money to Buy This Beaten-Down Stock.
New to Growth Stocks? Here's 1 Every Investor Should Have on Their Radar.
1 Reason Take-Two Stock Could Surprise Investors (Hint: It's Not Grand Theft Auto)
Own AMC Stock? This Is the 1 Thing to Watch Now.
NVDY: Good Option For Risk Averse Investors But Gains Could Be Capped
Is BYD Stock Your Ticket to Becoming a Millionaire?
2 Artificial Intelligence (AI) Stocks to Buy Before They Soar Under President Trump
This Super Software Stock Is Up 1,100% Since Its 2019 IPO, but Its Momentum Is Stalling. What Should Investors Do From Here?
Should You Consider Vanguard S&P 500 ETF (VOO) Before the Next Market Shift?
Want to Invest Like a Billionaire? Here's 1 Stock Warren Buffett Just Purchased.
Prediction: This Monster Artificial Intelligence (AI) Chip Stock Will Soar in September (Hint: It's Not Nvidia)
First United: Upside Isn't Over Yet
Will Buying Archer Aviation Stock Below $10 Make Investors Rich?
EIC: Discounted Buybacks, Dividend Cut And CLO Exposure; A Wait-And-Watch Story
Meta Platforms and Apple Just Gave This Fellow "Magnificent Seven" Stock Great News
Stellantis to recall over 219,000 US vehicles due to an issue with rear-view camera, NHTSA says
3 Best Dividend Stocks to Buy Now
This Stock Is Crushing the S&P 500 in 2025 and Shows No Signs of Stopping
Could Walmart Become a Trillion-Dollar Company?
These Were the 5 Top-Performing Stocks in the S&P 500 in July 2025
Should You Buy Nvidia After Its Blowout Earnings Report? Here's What History Says.
Is Cava Stock Poised for an Nvidia-Level Run?
This ETF is Crushing the S&P 500. Here's Why It's a Simple Way to Invest in AI While Generating Passive Income from High-Yield Stocks.
Cytokinetics' drug more effective for heart disease symptoms than standard-of-care
Cytokinetics Announces Primary Results from MAPLE-HCM Presented at the European Society of Cardiology Congress 2025 and Published in The New England Journal Of Medicine
Is This a Good Move or Desperation From Tesla?
We're Witnessing Stock Market History: Potentially 3 Bubbles Are Occurring at the Same Time
7 Best Dividend Champions to Buy Now
Gold Is Smokin'. But There's One Way You Don't Want to Play It.
Merck Provides New Results for VERQUVO® (vericiguat) in Patients with Chronic Heart Failure and Reduced Ejection Fraction
IVVW: BlackRock Jumping Into The S&P 500 Buy-Write Arena, Offers High-Yield
Build-A-Bear Q2: Expanding Earnings Internationally As Brand Visibility Grows
IXP Vs. XLC: Three Hidden Investments To Add To A Communications Services Sector ETF
Panasonic's New Bets Look Likely To Pay Off
VGT Is Not A Victim Of Nvidia
$2 Billion Lower Amber Energy Bid Recommended by Special Master in CITGO Sale Process
JQUA: I Prefer This ETF Over SCHG Due To Concentration Risks
U.S. IPO Weekly Recap: Quiet Week As IPO Market Gears Up For A Busy Fall
Meta changes the way its AI chatbot responds to kids after senator launches probe into its conversations with teens
Arch Capital: Attractive Even With Slowing Premium Inflation
PagSeguro Is Still Growing Mid-Single-Digits Into A Challenging Cycle And Trades At 6x Earnings
C3.AI INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that C3.ai, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
FDG: Nontransparent ETF With Quality Holdings But High Beta, Unconvincing Returns
Victory Square Technologies Reports Q2 2025 Results Highlighted by Revenue Growth, Profitability, and Portfolio Momentum
American Aires Inc. Announces Business Continuity and Governance Actions Following Special Committee Review
MSP Recovery Announces Strategic Term Sheet Providing Prospective Liquidity and Working Capital Aimed at Driving Future Growth
Cracks are forming in Meta's partnership with Scale AI
In NCLA Amicus Win, en Banc Federal Circuit Rules Trump's Emergency Tariffs Are Unlawful
Solar Alliance Energy, Inc. Announces Q2 Earnings, through a challenging period for the solar renewables industry
Spirit Airlines files for second bankruptcy in under a year as low-cost carrier continues to struggle
CHTR INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Charter Communications, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit
Risk Disclosure:Derivatives are traded over-the-counter on margin, which means they carry a high level of risk and there is a possibility you could lose all of your investment. These products are not suitable for all investors. Please ensure you fully understand the risks and carefully consider your financial situation and trading experience before trading. Seek independent financial advice if necessary before opening an account with BCR.